Hanlim Pharm

Cyclosporin 0.5 mg eye drop for keratoconjunctivitis sicca (dry eye).

LODIEN (S-amlodipine) for hypertension and angina, and LODIVIKAR, an S-amlodipine and olmesartan medoxomil combination for essential hypertension.

Postmenopausal osteoporosis treatments combining sodium risedronate and cholecalciferol, in PLUS (35 mg / 5,600 IU) and M (150 mg / 30,000 IU) strengths.

Leflunomide tablet for rheumatoid arthritis, a conventional synthetic disease-modifying antirheumatic drug, in 10 mg and 20 mg strengths.

Subsidiary specializing in active pharmaceutical ingredients (APIs). Hanlim Pharm also has pharmaceutical distribution affiliate Hanlim MS and ophthalmology affiliate Hanlim Eye Health.

The rheumatoid arthritis drug Arei Tab. (10 mg and 20 mg) passed Severance Hospital's drug committee and entered its formulary as a replacement for the originator product.

Signed an industry–academia agreement with Sungkyunkwan University's College of Pharmacy covering scholarships, practical pharmaceutical training and field education for students, and joint research on medicines and the pharmaceutical industry.

Invested KRW 200 million in SmartinBio, a biotech venture developing treatments for diabetic retinopathy and cancer.